Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of PF-08046031 in advanced melanoma and other solid tumors was terminated. The trial status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PF-08046031

Snippet

Sponsor: Pfizer | Conditions: Malignant Melanoma, Melanoma | Phase 1 | Status: TERMINATED